MDB Capital Holdings, LLC (MDBH)
NASDAQ: MDBH · Real-Time Price · USD
4.270
-0.300 (-6.56%)
Apr 21, 2025, 4:00 PM EDT - Market closed
MDB Capital Holdings, LLC Revenue
In the year 2024, MDB Capital Holdings, LLC had annual revenue of $2.09M, down -65.21%. MDB Capital Holdings, LLC had revenue of $1.07M in the quarter ending December 31, 2024, with 15.99% growth.
Revenue (ttm)
$2.09M
Revenue Growth
-65.21%
P/S Ratio
20.65
Revenue / Employee
$130,353
Employees
16
Market Cap
42.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.09M | -3.91M | -65.21% |
Dec 31, 2023 | 6.00M | 4.78M | 391.81% |
Dec 31, 2022 | 1.22M | 11.05M | -112.40% |
Dec 31, 2021 | -9.83M | -13.29M | -384.85% |
Dec 31, 2020 | 3.45M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Berkshire Hathaway | 371.43B |
JPMorgan Chase & Co. | 168.73B |
Bank of America | 97.45B |
Wells Fargo & Company | 77.25B |
Morgan Stanley | 63.96B |
American Express Company | 62.05B |
HSBC Holdings | 61.25B |
The Goldman Sachs Group | 53.04B |
MDBH News
- 18 days ago - MDB Capital Holdings, LLC (MDBH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market - GlobeNewsWire
- 4 weeks ago - MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time - GlobeNewsWire
- 6 weeks ago - New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race - GlobeNewsWire
- 2 months ago - eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering - GlobeNewsWire
- 2 months ago - Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes - GlobeNewsWire
- 2 months ago - Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol - GlobeNewsWire
- 3 months ago - Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change - GlobeNewsWire